Mixed cryoglobulinemia

Orphanet Journal of Rare Diseases

Volumn 3, Issue 1, 2008, Pages

  Ferri, Clodoveo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

ADULT; AGED; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 54049101115     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-3-25     Document Type: Review

References (128)

1. Hyperproteinemia associated with multiple myeloma. With report of a case in which an extraordinary hyperproteinemia was associated with trombosis of the retinal veins and symptoms suggesting Raynaud's disease. M Wintrobe M Buell, Bull Johns Hopkins Hosp 1933 52 156 65
2. Cryoglobulinemia based on interaction between a gamma macroglobulin and 7S gamma globulin. J Lospalluto B Dorward W Miller Jr M Ziff, Am J Med 1962 32 142 145 10.1016/0002-9343(62)90191-2 14466769
3. Cryoglobulins (review). C Ferri AL Zignego SA Pileri, J Clin Pathol 2002 55 4 13 11825916
4. Biologic and clinical significance of cryoglobulins. JC Brouet JP Clouvel F Danon M Klein M Seligmann, Am J Med 1974 57 775 88 10.1016/0002-9343(74) 90852-3 4216269
5. Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. M Meltzer EC Franklin K Elias RT McCluskey N Cooper, Am J Med 1966 40 837 56 10.1016/0002-9343(66)90200-2 4956871
6. Mixed Cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. PD Gorevic HJ Kassab Y Levo R Kohn M Meltzer P Prose E Franklin, Am J Med 1980 69 287 308 10.1016/0002-9343(80)90390-3 6996482
7. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. F Invernizzi M Galli G Serino G Monti PL Meroni C Granatieri C Zanussi, Acta Haematol 1983 70 73 82 6408882
8. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. G Monti M Galli F Invernizzi P Pioltelli F Saccardo A Monteverde M Pietrogrande P Renoldi S Bombardieri G Bordin M Candela C Ferri A Gabrielli C Mazzaro S Migliaresi C Mussini E Ossi L Quintiliani G Tirri A Vacca GISC. Italian Group for the Study of Cryoglobulinaemias, QJM 1995 88 115 26 7704562
9. Mixed cryoglobulinemia as a model of systemic vasculitis. F Dammacco D Sansonno, Clin Rev Allergy Immunol 1997 15 97 119 10.1007/BF02828280 9209804
10. Cryoglobulinemic vasculitis (review). P Lamprecht A Gause WL Gross, Arthritis Rheum 1999 42 2507 16 10.1002/1529-0131(199912)42:12<2507::AID- ANR2>3.0.CO;2-# 10615995
11. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. C Ferri A Antonelli MT Mascia M Sebastiani P Fallahi D Ferrari SA Pileri AL Zignego, Dig Liver Dis 2007 39 Suppl 1 S13 21 10.1016/S1590-8658(07)80005-3 17936215
12. B-cells and mixed cryoglobulinemia. C Ferri A Antonelli MT Mascia S Sebastiani P Fallhai D Ferrari M Giunti SA Pileri AL Zignego, Autoimmun Rev 2007 7 114 20 10.1016/j.autrev.2007.02.019 18035320
13. Non HCV-related mixed cryoglobulinemia. MT Mascia D Ferrari D Campioli G Sandri C Mussini C Ferri, Dig Liver Dis 2007 39 Suppl 1 S61 64 10.1016/S1590-8658(07)80013-2 17936226
14. Hepatitis C virus infection in type II mixed cryoglobulinemia (review). G Abel QX Zhang V Agnello, Arthritis Rheum 1993 36 1341 9 10.1002/art.1780361003 8216392
15. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. J Pawlotsky B Mustapha C Andre M-C Voisin L Intrator F Roudot-Thoraval L Deforges C Duvoux E-S Zairani J Duval, Hepatology 1994 19 841 8 8138255
16. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. F Lunel L Musset P Cacoub L Frangeul P Cresta M Perrin P Grippon C Hoang D Valla JC Piette, Gastroenterology 1994 106 1291 300 7513667
17. Approach to the patient with chronic hepatitis C virus infection. SK Herrine, Ann Intern Med 2002 136 747 57 12020143
18. Erectile dysfunction and hepatitis C virus infection. C Ferri MA Bertozzi AL Zignego, JAMA 2002 288 698 9 10.1001/jama.288.6.698 12169072
19. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. A Monteverde M Ballarè S Pileri, Springer Semin Imunopathol 1997 19 99 110 10.1007/BF00945028
20. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. G Pozzato C Mazzaro M Crovatto ML Modolo S Ceselli G Mazzi S Sulfaro F Franzin P Tulissi M Moretti GF Santini, Blood 1994 84 3047 53 7949176
21. Detection and distribution of hepatitis C-related proteins in lymph nodes of patients with type II cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. D Sansonno S De Vita V Cornacchiulo A Carbone M Baiocchi F Dammacco, Blood 1996 88 4638 45 8977256
22. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. F Dammacco D Sansonno C Piccoli V Racanelli FP D'Amore G Lauletta, Semin Liver Dis 2000 20 143 57 10.1055/s-2000-9613 10946420
23. Evaluation of cryoglobulins. U Kallemuchikkal PD Gorevic, Arch Pathol Lab Med 1999 123 119 25 10050784
24. Mixed cryoglobulinemia: demographic, clinical, and serological features, and survival in 231 patients. C Ferri M Sebastiani D Giuggioli M Cazzato G Longombardo A Antonelli R Puccini C Michelassi AL Zignego, Sem Arthritis Rheum 2004 33 355 74 10.1016/j.semarthrit.2003.10.001
25. Cryoglobulinemic vasculitis: Review. C Ferri MT Mascia, Curr Opin Rheumatol 2006 18 54 63 16344620
26. Cryoglobulins and immune complexes in essential mixed cryoglobulinemia. S Bombardieri C Ferri P Migliorini A Pontrandolfo A Puccetti C Vitali G Pasero, Ric Clin Lab 1986 16 2 281 288 2947311
27. Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients. C Ferri L Mannini V Bartoli G Gremignai F Genovesi-Ebert R Cristofani B Albanese G Pasero S Bombardieri, Clin Exp Rheumatol 1990 8 271 81 2379342
28. Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome. P Fadda L La Civita AL Zignego C Ferri, Reumatismo 2002 54 316 23 12563365
29. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiological investigations. C Ferri L La Civita C Cirafisi G Siciliano G Longombardo S Bombardieri B Rossi, J Rheumatol 1992 19 889 95 1328632
30. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. A Ammendola S Sampaolo L Ambrosone E Ammendola G Ciccone S Migliaresi G Di Iorio, Muscle Nerve 2005 31 382 5 10.1002/mus.20184 15515001
31. Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia. L Di Lullo FG De Rosa R Coviello ML Sorgi G Coen LR Zorzin M Casato, Clin Exp Rheumatol 1998 16 506 9706438
32. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. L La Civita AL Zignego F Lombardini M Monti G Longombardo G Pasero C Ferri, J Rheumatol 1996 23 1641 3 8877939
33. Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment. O Lidove P Cacoub P Hausfater B Wechsler C Frances JM Leger JC Piette, Gastroenterol Clin Biol 1999 23 403 6 10384347
34. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. M Casato D Saadoun A Marchetti N Limal C Picq P Pantano D Galanaud R Cianci P Duhaut JC Piette M Fiorilli P Cacoub, J Rheumatol 2005 32 484 8 15742440
35. Cryoglobulinaemia in human renal diseases. A study of seventy-six cases. P Druet P Letonturier A Contet C Mandet, Clin Exp Immunol 1973 15 483 96 4778718
36. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders. G Longombardo C Ferri S Marchi F Costa F Lombardini L Vacri S Bombardieri P Migliorini, Clin Immunol Immunopathol 1998 87 124 9 10.1006/clin.1997.4498 9614926
37. Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Y Uchiyama-Tanaka Y Mori N Kishimoto A Nose Y Kijima T Nagata Y Umeda H Masaki H Matsubara T Iwasaka, Clin Nephrol 2004 61 144 50 14989635
38. Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. A Sabbatini MP Dolcher B Marchini D Chimenti S Moscato F Pratesi S Bombardieri P Migliorini, Clin Exp Rheumatol 1997 15 655 8 9444422
39. Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis. L Quartuccio M Fabris S Salvin M Isola F Soldano E Falleti CA Beltrami V De Re S De Vita, Rheumatology (Oxford) 2007 46 1657 61 10.1093/rheumatology/kem209 17893101
40. Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia. G Kaplanski T Maisonobe V Marin S Grès S Robitail C Farnarier JR Harlé JC Piette P Cacoub, J Hepatol 2005 42 334 340 10.1016/j.jhep.2004.11.034 15710215
41. Lung involvement in essential mixed cryoglobulinemia. S Bombardieri P Paoletti C Ferri O Di Munno E Fornai C Giuntini, Am J Med 1979 66 748 56 10.1016/0002-9343(79)91112-4 443251
42. Mixed cryoglobulinemia: effect of alpha-interferon on subclinical lymphocytes alveolitis. F Salaffi P Manganelli M Carotti S Subiaco C Cervini, Clin Exp Rheumatol 1996 14 219 20 8737733
43. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. C Ferri L La Civita P Fazzi S Solfanelli F Lombardini N Begliomini M Monti G Longombardo G Pasero AL Zignego, Br J Rheumatol 1997 36 360 5 10.1093/rheumatology/36.3.360 9133969
44. Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus. P Manganelli F Salaffi S Subiaco M Carotti C Cervini G Consigli M Majori A Pesci, Br J Rheumatol 1996 35 978 82 10.1093/rheumatology/ 35.10.978 8883436
45. Hypercomplementaemia as a marker of the evolution from benign to malignant B-cell proliferation in patients with type II mixed cryoglobulinaemia. C Vitali C Ferri P Nasti L La Civita M Mazzantini G Longombardo S Bombardieri, Br J Rheumatol 1994 33 791 2 10.1093/rheumatology/33.8.791 8055216
46. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. A Antonelli C Ferri P Fallahi D Giuggioli C Nesti G Longombardo P Fadda A Pampana M Maccheroni E Ferrannini, QJM 2004 97 499 506 10.1093/qjmed/hch088 15256607
47. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. A Antonelli C Ferri P Fallahi M Sebastiani C Nesti L Barani R Barale E Ferrannini, Rheumatology (Oxford) 2004 43 238 40 10.1093/rheumatology/keh011 13130149
48. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. A Antonelli C Ferri P Fallahi C Nesti AL Zignego M Maccheroni, Clin Exp Rheumatol 2002 20 693 6 12412202
49. Erectile dysfunction and hepatitis C virus infection. C Ferri MA Bertozzi AL Zignego, JAMA 2002 288 698 9 10.1001/jama.288.6.698 12169072
50. Thyroid cancer in patients with hepatitis C infection. A Antonelli C Ferri P Fallahi, JAMA 1999 281 1588 10.1001/jama.281.17.1588 10235149
51. Alpha-Interferon in Mixed Cryoglobulinemia patients: a randomized crossover controlled trial. C Ferri E Marzo G Longombardo F Lombardini L La Civita R Vanacore AM Liberati R Gerli F Greco A Moretti M Monti P Gentilini S Bombardieri AL Zignego, Blood 1993 81 1132 6 8382969
52. Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia. L Di Lullo FG De Rosa R Coviello ML Sorgi G Coen LR Zorzin M Casato, Clin Exp Rheumatol 1998 16 506 9706438
53. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. L La Civita AL Zignego F Lombardini M Monti G Longombardo G Pasero C Ferri, J Rheumatol 1996 23 1641 3 8877939
54. Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment. O Lidove P Cacoub P Hausfater B Wechsler C Frances JM Leger JC Piette, Gastroenterol Clin Biol 1999 23 403 6 10384347
55. Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. A Antonelli C Ferri P Fallahi M Sebastiani C Nesti L Barani R Barale E Ferrannini, Rheumatology (Oxford) 2004 43 238 40 10.1093/rheumatology/keh011 13130149
56. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. SH Mehta FL Brancati MS Sulkowski SA Strathdee M Szklo DL Thomas, Ann Intern Med 2000 133 592 9 11033586
57. HCV infection: pathogenesis, clinical manifestations and therapy. A Antonelli C Ferri M Galeazzi C Giannitti D Manno G Mieli-Vergani E Menegatti I Olivieri M Puoti C Palazzi D Roccatello D Vergani P Sarzi-Puttini F Atzeni, Clin Exp Rheumatol 2008 26 1 Suppl 48 S39 47 18570753
58. mixed cryoglobulinemia, type II: a manifestation of low malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. A Monteverde MT Rivano GC Allegra AI Monteverde P Zigrossi P Baglioni M Gobbi B Falini G Bordin S Pileri, Acta Haematol 1988 79 20 25 3124457
59. Hepatitis C virus, B-cell disorders, and non-Hodgkin's lymphoma. C Ferri S Pileri AL Zignego, Infectious causes of cancer: targets for intervention. National Cancer Institute (NIH) Totowa, NJ: The Humana Press Inc, Goedert JJ, 2000 349 368
60. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. G Pozzato C Mazzaro Crovatto ML Modolo S Ceselli G Mazzi S Sulfaro F Franzin P Tulissi M Moretti GF Santini, Blood 1994 84 3047 53 7949176
61. Mixed cryoglobulinemia as a possible preneoplastic disorder. L La Civita AL Zignego M Monti G Longombardo G Pasero C Ferri, Arthritis Rheum 1995 38 1859 60 10.1002/art.1780381222 8849361
62. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. G Monti P Pioltelli F Saccardo M Campanini M Candela G Cavallero S De Vita C Ferri C Mazzaro S Migliaresi E Ossi M Pietrogrande A Gabrielli M Galli F Invernizzi, Arch Intern Med 2005 165 101 5 10.1001/archinte.165.1.101 15642884
63. Prevalence of BCL-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. AL Zignego C Ferri F Giannelli C Giannini P Caini M Monti EM Marrocchi E Di Pietro G La Villa G Laffi P Gentilini, Ann Intern Med 2002 137 571 80 12353944
64. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. C Ferri F Caracciolo AL Zignego L La Civita M Monti G Longombardo F Lombardini F Greco E Capochiani A Mazzoni C Mazzaro G Pasero, Br J Haematol 1994 88 392 4 10.1111/j.1365-2141.1994.tb05036.x 7803287
65. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. K Matsuo A Kusano A Sugumar S Nakamura K Tajima NE Mueller, Cancer Sci 2004 95 745 52 10.1111/j.1349-7006.2004.tb03256.x 15471561
66. Association between hepatitis B virus and essential mixed cryoglobulinemia. Y Levo PD Gorevic HJ Kassab D Zucker-Franklin EC Franklin, N Engl J Med 1977 296 1501 4 865530
67. Isolation of a cDNA clone derived from a blood-borne non- A non-B viral hepatitis genome. GL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton, Science 1989 244 359 61 10.1126/science.2523562 2523562
68. Hepatitis C virus in patients with Cryoglobulinemia type II. M Pascual L Perrin E Giostra JA Schifer, J Infect Dis 1990 162 569 70 2115556
69. Alpha-interferon in the treatment of mixed cryoglobulinemia patients. International Cancer Update. Focus on Interferon Alfa 2b. Cannes, France. November 1-4, 1990. C Ferri E Marzo G Longombardo F Lombardini F Greco S Bombardieri, Proceedings, Eur J Cancer 1991 27 81 2
70. Association between hepatitis C virus and mixed cryoglobulinemia. C Ferri F Greco G Longombardo P Palla E Marzo A Moretti A Mazzoni G Pasero S Bombardieri P Highfield T Corbishley, Clin Exp Rheumatol 1991 9 621 4 1662567
71. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. R Misiani P Bellavita D Fenili G Borelli D Marchesi M Massazza G Vendramin B Comotti E Tanzi G Scudeller, Ann Intern Med 1992 117 573 7 1326246
72. A role for hepatitis C virus infection in type II cryoglobulinemia. V Agnello RT Chung LM Kaplan, N Engl J Med 1992 327 1490 5 1383822
73. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. C Ferri M Monti L La Civita G Longombardo F Greco G Pasero P Gentilini S Bombardieri AL Zignego, Blood 1993 82 3701 4 8260706
74. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations (review). S Gumber S Chopra, Ann Intern Med 1995 123 615 20 7677303
75. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. S De Vita D Sansonno R Dolcetti G Ferraccioli A Carbone V Cornacchiulo G Santini M Crovatto A Gloghini F Dammacco M Boiocchi, Blood 1995 86 1887 92 7655017
76. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. V Agnello G Abel, Arthritis Rheum 1997 40 2007 15 10.1002/art.1780401113 9365090
77. Infection of peripheral mononuclear blood cells by hepatitis C virus. AL Zignego D Macchia M Monti V Thiers M Mazzetti M Foschi E Maggi S Romagnani P Gentilini C Bréchot, J Hepatol 1992 15 382 6 10.1016/0168-8278(92)90073-X 1332999
78. Binding of hepatitis C virus to CD81. P Pileri Y Uematsu S Campagnoli G Galli F Falugi R Petracca AJ Weiner M Houghton D Rosa G Grandi S Abrignani, Science 1998 282 938 41 10.1126/science.282.5390.938 9794763
79. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach: Review. AL Zignego C Ferri SA Pileri P Caini FB Bianchi for the Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV infection, Dig Liver Dis 2007 39 2 17 10.1016/j.dld.2006.06.008 16884964
80. HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. D Sansonno FA Tucci V De Re G Lauletta M Montrone M Libra F Dammacco, Hepatology 2005 42 1019 27 10.1002/hep.20887 16231354
81. Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. C Giannini F Giannelli AL Zignego, Hepatology 2005 42 1019 27 10.1002/hep.20887 16231354
82. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. K Machida KT Cheng VM Sung S Shimodaira KL Lindsay AM Levine MY Lai MM Lai, Proc Natl Acad Sci USA 2004 101 4262 7 14999097 10.1073/pnas.0303971101
83. Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia. S Migliaresi A Bresciani L Ambrosone M Spera D Barbarulo V Lombari G Pirozzi G Borgia ML Lombardi G Tirri C Manzo, Ann Rheum Dis 2000 59 20 5 10627422 10.1136/ard.59.1.20
84. Role of the HLA class II: HCV-related disorders. V De Re L Caggiari MP Simula S De Vita C Mazzaro M Lenzi GM Massimo G Monti C Ferri AL Zignego A Gabrielli D Sansonno F Dammacco M Libra N Sacchi R Talamini M Spina U Tirelli R Cannizzaro R Dolcetti, Ann N Y Acad Sci 2007 1107 308 18 10.1196/annals.1381.033 17804559
85. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. AN Dimitrakopoulos T Kordossis A Hatzakis HM Moutsopoulos, Ann Intern Med 1999 130 226 30 10049201
86. Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection. G Scotto DC Cibelli A Saracino R Prato E Palumbo V Fazio T Scarabaggio L Monno G Angarano, J Infect 2006 52 294 9 10.1016/j.jinf.2005.05. 025 16026843
87. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. AG Tzioufas DS Boumba FN Skopouli HM Moutsopoulos, Arthritis Rheum 1996 39 767 72 10.1002/art.1780390508 8639173
88. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. M Lenzi PJ Johnson IG McFarlane G Ballardini HM Smith BM McFarlane C Bridger D Vergani FB Bianchi R Williams, Lancet 1991 338 277 80 10.1016/0140-6736(91)90418-O 1677111
89. Hepatitis C virus as common cause of mixed cryoglobulinemia and chronic liver disease. C Ferri G Longombardo L La Civita F Greco F Lombardini R Cecchetti MA Cagianelli S Marchi M Monti AL Zignego MP Manns, J Intern Med 1994 236 31 6 8021570
90. Hepatitis C-associated arthritis. D Buskila, Curr Opin Rheumatol 2000 12 295 9 10.1097/00002281-200007000-00011 10910182
91. Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. MH Wener K Hutchinson C Morishima DR Gretch, Arthritis-Rheum 2004 50 2305 8 10.1002/art.20355 15248231
92. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. M Bombardieri C Alessandri G Labbadia C Iannuccelli F Carlucci V Riccieri V Paoletti G Valesini, Arthritis Res Ther 2004 6 137 41 10.1186/ar1041
93. Hepatitis c virus infection mimicking primary Sjogren's syndrome: a clinical and immunologic description of 35 cases. M Ramos-Casals M García-Carrasco R Cervera J Rosas O Trejo G de la Red JM Sánchez-Tapias J Font M Ingelmo, Medicine (Baltimore) 2001 80 1 8 10.1097/00005792-200101000-00001 11204499
94. Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease. VI Vasil'ev NA Probatova EIu Varlamova NN Tupitsin MV Simonova TN Safonova LA Bozh'eva NS Shornikova OA Logvinenko GIu Belenin, Ter Arkh 2004 76 61 8 15471400
95. Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. M Ramos-Casals S De Vita A Tzioufas, Autoimmun Rev 2005 4 8 15 10.1016/j.autrev.2004.04.004 15652773
96. Sjogren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. M Ramos-Casals V Loustaud-Ratti S De Vita M Zeher JA Bosch E Toussirot F Medina J Rosas JM Anaya J Font SS-HCV Study Group, Medicine 2005 84 81 9 10.1097/01.md.0000157397.30055.c9 15758837
97. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. M Ramos-Casals P Brito-Zerón J Yagüe M Akasbi R Bautista M Ruano G Claver V Gil J Font, Rheumatology (Oxford) 2005 44 89 94 10.1093/rheumatology/keh407 15381790
98. Long term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. JPA Ioannidis VA Vassiliou HM Moutsopoulos, Arth Rheum 2002 46 741 7 10.1002/art.10221
99. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. C Vitali S Bombardieri R Jonsson HM Moutsopoulos EL Alexander SE Carsons TE Daniels PC Fox RI Fox SS Kassan SR Pillemer N Talal MH Weisman European Study Group on Classification Criteria for Sjögren's Syndrome, Ann Rheum Dis 2002 61 554 8 12006334 10.1136/ard.61.6.554
100. Outcome measures for Sjogren's syndrome, april 10-11, 2003, Bethesda, Maryland, USA. SR Pillemer J Smith P Fox SJ Bowman, J Rheumatol 2005 31 1 143 149
101. Metodologie di studio e protocolli diagnostici. Italian Group for the Study of Cryoglobulinemias (GISC) C Ferri Ed, S. Margherita di Pula, Cagliari 1989
102. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. JD Tissot JA Schifferli DF Hochstrasser C Pasquali F Spertini F Clement S Frutiger N Paquet GJ Hughes P Schneider, J Immunol Methods 1994 173 63 75 10.1016/0022-1759(94) 90284-4 8034987
103. A "missed" cryoglobulin: the importance of in vitro calcium concentration. M André H Mahammedi O Aumaitre A Tridon JD Tissot JC Piette, Ann Rheum Dis 2000 59 490 2 10.1136/ard.59.6.490a
104. Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications. MU Mondelli I Zorzoli A Cerino A Cividini M Bissolati L Segagni V Perfetti E Anesi P Garini G Merlini, J Hepatol 1998 29 879 86 10.1016/S0168-8278(98)80114-1 9875633
105. Relapse of Hepatitis C Virus-Associated Mixed Cr yoglobulinemia Vasculitis in Patients With Sustained Viral Response. D Landau D Saadoun F Halfon M Martinot-Peignoux P Marcellin E Fois P Cacoub, Arthritis Rheum 2008 58 604 11 10.1002/art.23305 18240235
106. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia. M Casato B Lagana G Antonelli F Dianzani L Bonomo, Blood 1991 78 3142 785 1742481
107. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. R Misiani P Bellavita D Fenili O Vicari D Marchesi PL Sironi P Zilio A Vernocchi M Massazza G Vendramin, N Engl J Med 1994 330 751 6 10.1056/NEJM199403173301104 8107741
108. Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. D Vassilopoulos LH Calabrese, Arthritis Rheum 2002 46 585 97 10.1002/art.10107 11920393
109. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to a-interferon therapy. C Mazzaro F Franzin P Tulissi E Pussini M Crovatto GS Carniello, Cancer 1996 77 2604 13 10.1002/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V 8640712
110. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. R Misiani P Bellavita P Baio R Caldara S Ferruzzi P Rossi F Tengattini, Nephrol Dial Transplant 1999 14 1558 60 10.1093/ndt/14.6.1558 10383026
111. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. E Zuckerman D Keren G Slobodin I Rosner M Rozenbaum E Toubi E Sabo I Tsykounov JE Naschitz D Yeshurun, J Rheumatol 2000 27 2172 8 10990230
112. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. JG McHutchison SC Gordon ER Schiff ML Shiffman WM Lee VK Rustgi, N Engl J Med 1998 339 1485 92 10.1056/NEJM199811193392101 9819446
113. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. C Mazzaro F Zora M Caizzi C Donada G Di Gennaro K Dal Maso G Carniello L Virgolini U Tirelli G Pozzato, J Hepatol 2005 42 632 8 10.1016/j.jhep.2004.10.031 15826710
114. Antiviral therapy for hepatitis C virus - associated mixed cryoglobulinemia vasculitis: a long-term followup study. D Saadoun M Resche-Rigon V Thibault JC Piette P Cacoub, Arthritis Rheum 2006 54 3696 706 10.1002/art.22168 17075881
115. Scavenger Receptor Class B is Required for Hepatitis C Virus Uptake and Cross-presentation by Human Dendritic Cells. H Barth EK Schnober C Neumann-Haefelin C Thumann MB Zeisel HM Diepolder Z Hu TJ Liang HE Blum R Thimme M Lambotin TF Baumert, J Virol 2008 82 3466 79 18216094 10.1128/JVI.02478-07
116. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. F Zaja S De Vita C Mazzaro S Sacco D Damiani G De Marchi A Michelutti M Baccarani R Fanin G Ferraccioli, Blood 2003 101 3827 34 10.1182/blood-2002-09-2856 12560225
117. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. D Sansonno V De Re G Lauletta FA Tucci M Boiocchi F Dammacco, Blood 2003 101 3818 26 10.1182/blood-2002-10-3162 12506023
118. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. D Roccatello S Baldovino D Rossi M Mansouri C Naretto M Gennaro R Cavallo M Alpa P Costanzo O Giachino G Mazzucco LM Sena, Nephrol Dial Transplant 2004 19 3054 61 10.1093/ndt/gfh469 15494358
119. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? P Cacoub A Delluc D Saadoun DA Landau D Sene, Ann Rheum Dis 2008 67 283 7 10.1136/ard.2006.065565 17644544
120. Treatment of renal involvement in essential mixed cryoglobulinemia with prolonged plasma exchance. C Ferri L Moriconi G Gremignai P Migliorini G Paleologo PV Fosella S Bombardieri, Nephron 1986 43 246 51 3736735
121. Double filtration plasmapheresis in the treatment of cryoglobulinemic glomerulonephritis. L Moriconi C Ferri R Puccini G Casto R Baronti R Cecchetti G Gremignai L Cioni S Bombardieri, Int J Art Org 1989 12 S4 83 6
122. Low-antigen-content diet in the treatment of mixed cryoglobulinemia patients. C Ferri M Pietrogrande C Cecchetti A Tavoni A Cefalo G Buzzetti C Vitali S Bombardieri, Am J Med 1989 87 519 24 2816967
123. Low-antigen-content diet in the treatment of patients with IgA nephropathy. C Ferri R Puccini G Longombardo G Paleologo P Migliorini L Moriconi G Pasero L Cioni, Nephrol Dial Transplant 1993 8 11 1193 1198 8302454
124. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. P Lamprecht C Lerin-Lozano H Merz RH Dennin A Gause J Voswinkel SO Peters O Gutzeit AC Arlt W Solbach WL Gross, Ann Rheum Dis 2003 62 1230 3 14644867 10.1136/ard.2002.004929
125. Rituximab combined with Peg-Interferon-Ribavirin in refractory HCV-associated cryoglobulinemia vasculitis. D Saadoun M Resche-Rigon D Sene L Perard JC Piette P Cacoub, Ann Rheum Dis 2008 Jan 4
126. Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients. M Galeazzi F Bellisai S Manganelli G Morozzi GD Sebastiani, Autoimmun Rev 2006 5 493 8 10.1016/j.autrev.2006.01.002 16920576
127. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. NN Zein for the Etanercept Study Group, J Hepatol 2005 42 315 22 10.1016/j.jhep.2004.11.025 15791697
128. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections. Review. D Vassilopoulos LH Calabrese, Curr Opin Rheumatol 2007 19 619 25 10.1097/BOR.0b013e3282f05b63 17917544